Tower Research Capital (TRC)’s PureTech Health PRTC Stock Holding History

Tower Research Capital (TRC)’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-73	Closed	-$1.71K	–	5922
2024 Q2	$1.71K	Sell	73 -64	-47%	-$1.79K	﹤0.01%	5106
2024 Q1	$3.92K	Buy	137 +94	+219%	+$2.4K	﹤0.01%	4769
2023 Q4	$1.18K	Buy	43 +41	+2,050%	+$835	﹤0.01%	5419
2023 Q3	$46	Buy	+2	New	+$54	﹤0.01%	5787

Other funds holding PRTC

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s PRTC Position: Q3 2024 in Review

Tower Research Capital (TRC) sold out of PureTech Health (PRTC) in Q3 2024, closing a stake of 73 shares — an estimated $1.71K sold.

Tower Research Capital (TRC) first reported a position in PRTC in Q3 2023 and held it in 4 quarters. The position peaked at $3.92K in Q1 2024. 4 funds tracked by Wall St. Rank hold PRTC as of Q3 2024.

Tower Research Capital (TRC) reported no remaining PureTech Health position as of Q3 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 73 PureTech Health shares in Q3 2024, an estimated $1.71K.
Tower Research Capital (TRC) first reported a position in PureTech Health in Q3 2023 and held it in 4 quarters.
Tower Research Capital (TRC)'s PureTech Health position peaked at $3.92K in Q1 2024.
4 funds tracked by Wall St. Rank held PureTech Health as of Q3 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.